Inhibition of simian virus 40 large tumor antigen expression in human fetal glial cells by an antisense oligodeoxynucleotide delivered by the JC virus-like particle

Human Gene Therapy

Volumn 15, Issue 11, 2004, Pages 1077-1090

  Wang, Meilin ^a,b   Tsou, Tsung Hsuan ^a,b   Chen, Li Sheng ^a   Ou, Wei Chih ^c   Chen, Pei Lain ^c   Chang, Chi Fang ^a   Fung, Chiung Yau ^a   Chang, Deching ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA; ONCOPROTEIN; VIRUS LARGE T ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASTROCYTOMA CELL; CANCER CELL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA PACKAGING; EXPRESSION VECTOR; FETUS; FETUS CELL; GENE TARGETING; GENETIC TRANSDUCTION; GLIA CELL; GLIOBLASTOMA; GLIOBLASTOMA CELL; HUMAN; HUMAN CELL; JC VIRUS; NEUROBLASTOMA CELL; NEUROLOGIC DISEASE; NEUROTROPIC VIRUS; NEUROTROPISM; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN EXPRESSION; RECOMBINANT DNA TECHNOLOGY; RECOMBINANT JC VIRUS PARTICLE; SIMIAN VIRUS 40; VIRUS CAPSID; VIRUS PARTICLE;

ANNEXIN A5; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; BLOTTING, WESTERN; BRAIN; CELL LINE, TUMOR; CELLS, CULTURED; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; HYDROGEN-ION CONCENTRATION; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MICROSCOPY, PHASE-CONTRAST; NERVOUS SYSTEM DISEASES; NEUROGLIA; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PROMOTER REGIONS (GENETICS); PROPIDIUM; TIME FACTORS; TRANSFECTION; ULTRAVIOLET RAYS;

JC VIRUS; MIRIDAE; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 9244230615     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2004.15.1077     Document Type: Article

References (48)

1. ABBING, A., BLASCHKE, U.K., GREIN, S., KRETSCHMAR, M., STARK, C.M.B., THTES, M.J.W., WALTER, J., WEIGAND, M., WOITH, D.C., HESS, J., and REISER, C.O.A. (2004). Efficient intracellular delivery of a protein and a low molecular weight substance via recombinant polyomavirus-like particles. J. Biol. Chem. 279, 27410-27421.
2. BARBANTI-BRODANO, G., SWETLY, P., and KOPROWSKI, H. (1970). Early events in the infection of permissive cells with simian virus 40: Adsorption, penetration, and uncoating. J. Virol. 6, 78-86.
3. CAPARROS-WANDERLEY, W., CLARK, B., and GRIFFIN, B.E. (2004). Effect of dose and long-term storage on immunogenicity of murine polyomavirus VP1 virus-like particles. Vaccine 22, 352-361.
4. CARBONE, M., RIZZO, P., GRIMLEY, P.M., PROCOPIO, A., MEW, D.I.Y., SHRIDHAR, V., DEBARTOLOMIES, A., ESPOSITO, V., GIULIANO, M.T., STEINBERG, S.M., LEVINE, A.S., GIORDANO, A., and PASS, H.I. (1997). Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat. Med. 3, 908-912.
5. CHANG, D.C., FUNG, C.Y., OU, W.C., CHAO, P.C., LI, S.Y., WANG, M.L., HUANG, Y.L., TZENG, T.Y., and TSAI, R.T. (1997). Self-assembly of the JC virus major capsid protein VP1 expressed in insect cells. J. Gen. Virol. 78, 1435-1439.
6. CHEN, B.J., and ATWOOD, W.J. (2002). Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism. Virology 300, 282-290.
7. CHEN, P.L., WANG, M.L., OU, W.C., LII, C.K., and CHANG, D.C. (2001). Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions from chelation. FEBS Lett. 500, 109-113.
8. CLARK, B., CAPARRÓS-WANDERLEY, W., MUSSELWHITE, G., KOTECHA, M., and GRIFFIN, B.E. (2001). Immunity against both polyomavirus VP1 and transgene product induced following intranasal delivery of VP1 pseudocapsid-DNA complexes. J. Gen. Virol. 82, 2791-2797.
9. EASH, S., TAVARES, R., STOPA, E.G., ROBBINS, S.H., BROSSAY, L., and ATWOOD, W.J. (2004). Differential distribution of the JC virus receptor-type sialic acid in normal human tissues. Am. J. Pathol. 164, 419-428.
10. FORSTOVA, J., KRAUZEWICZ, N., ELLIOTT, J., PALKOVA, Z., STRAUSS, M., and GRIFFIN, B.E. (1995). Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum. Gene Ther. 6, 297-306.
11. FRISQUE, R.J., BREAM, G.L., and CANNELLA, M.T. (1984). Human polyomavirus JC virus genome. J. Virol. 51, 458-469.
12. FROST, E., and BOURGAUX, P. (1975). Decapsidation of polyomavirus: Identification of subviral species. Virology 68, 245-255.
13. GOLDMANN, C., PETRY, H., FRYE, S., ASTO, A., EBITSCH, S., JENTSCH, K.D., KAUP, F.J., WEBER, R., TREBST, C., NISSLEIN, T., HUNSMANN, G., WEBER, T., and LUKE, W. (1999). Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: Formation of virus-like particles useful for immunological and therapeutic studies. J. Virol. 73, 4465-4469.
14. GOLDMANN, C., STOLTE, N., NISSLEIN, T., HUNSMANN, G., LUKE, W., and PETRY, H. (2000). Packaging of small molecules into VP1-Virus-like particles of the human polyomavirus JC virus. J. Virol. Methods 90, 85-90.
15. HALE, A.D., BARTKEVICIUTE, D., DARGEVICIUTE, A., JIN, L., KNOWLES, W., STANIULIS, J., BROWN, D.W.G., and SASNAUSKAS, K. (2002). Expression and antigenic characterization of the major capsid proteins of human polyomavirus BK and JC in Saccharomyces cerevisiae. J. Virol. Methods 104, 93-98.
16. HEIDARI, S., KRAUZEWICZ, N., KALANTARI, M., VLASTOS, A., GRIFFIN, B.E., and DALIANIS, T. (2000). Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus. J. Virol. 74, 11963-11965.
17. HIRT, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369.
18. JENSEN, P.N., and MAJOR, E.O. (1999). Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. J. Leukoc. Biol. 65, 428-438.
19. KHALILI, K., VALLE, L.D., OTTE, J., WEAVER, M.W., and GORDON, J. (2003). Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene 22, 5181-5191.
20. KOMAGOME, R., SAWA, H., SUZUKI, T., SUZUKI, Y., TANAKA, S., ATWOOD, W.J., and NAGASHIMA, K. (2002). Oligosaccharides as receptors for JC virus. J. Virol. 76, 12992-13000.
21. KRAUZEWICZ, N., COX, C., SOEDA, E., CLARK, B., RAYNER, S., and GRIFFIN, B.E. (2000). Sustained ex vivo and in vivo transfer of a reporter gene using polyoma virus pseudocapsids. Gene Ther. 7, 1094-1102.
22. LIU, C.K., WEI, G., and ATWOOD, W.J. (1998). Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal α(2-6)-linked sialic acids. J. Virol. 72, 4643-4649.
23. OPPENHEIM, A., PELEG, A., FIBACH, E., and RACHMILEWITZ, E.A. (1986). Efficient introduction of plasmid DNA into human hemopoietic cells by encapsidation in simian virus 40 pseudovirions. Proc. Natl. Acad. Sci. U.S.A. 83, 6925-6929.
24. OSTERMAN, J.V., WADDELL, A., and APOSHIAN, H.V. (1970). DNA and gene therapy: Uncoating of polyoma pseudovirus in mouse embryo cells. Proc. Natl. Acad. Sci. U.S.A. 67, 37-40.
25. OU, W.C., TSAI, R.T., WANG, M.L., FUNG, C.Y., HSEU, T.H., and CHANG, D.C. (1997). Genomic cloning and sequencing of Taiwan-3 JC virus from the urine of a rheumatoid arthritis patient. J. Formos. Med. Assoc. 96, 511-516.
26. OU, W.C., WANG, M.L., FUNG, C.Y., TSAI, R.T., CHAO, P.C., HSEU, T.H., and CHANG, D.C. (1999). The major capsid protein VP1 of human JCV expressed in E. coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. J. Gen. Virol. 80, 39-46.
27. OU, W.C., WANG, M.L., CHANG, H., TSAY, G.J., HSEU, T.H., and CHANG, D.C. (2001). Identification of a DNA encapsidation sequence for human polyomavirus pseudovirion formation. J. Med. Virol. 64, 366-373.
28. PADGETT, B.L., WALKER, D.L., ZURHEIN, G.M., and ECKROADE, R.J. (1971). Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1, 1257-1260.
29. PHO, M.T., ASHOK, A., and ATWOOD, W.J. (2000). JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 74, 2288-2292.
30. QU, O., SAWA, H., SUZUKI, T., SEMBA, S., HENMI, C., OKADA, Y., TSUDA, M., TANAKA, S., ATWOOD, W.J., and NAGASHIMA, K. (2004). Nuclear entry mechanism of the human polyomavirus JC virus like particle: Role of importins and the nuclear pore complex. J. Biol. Chem. 279, 27735-27742.
31. ROHMANN, A., HENKE, S., ZIMMER, A., BERTLING, W.M., and DINGERMANN, T. (2000). Oligonucleotide delivery by recombinant polyoma virus like particles. Presented at the Annual Convention of the German Pharmaceutical Society, Frankfurt am Main, Germany, February, 2000. Available at URL http://www.kfunigraz.ac.at/ipcwww/docs/her2_dphg2000.pdf.
32. SABATH, B.F., and MAJOR, E.O. (2002). Traffic of JC virus form sites of initial infection to the brain: The path to progressive multifocal leukoencephalopathy. J. Infect. Dis. 186(Suppl. 2), S180-S186.
33. SANDALON, Z., DALYOT-HEMAN, N., OPPENHELM, A.B., and OPPENHELM, A. (1997). In vitro assembly of SV40 virions and pseudovirions: Vector development for gene therapy. Hum. Gene Ther. 8, 843-849.
34. SASNAUSKAS, K., BULAVAITE, A., HALE, A., JIN, L., KNOWLES, W.A., DARGEVICIUTE A., BARTKEVICIUTE, D., ZVIRBLIENE, A., STANIULIS, J., BROWN, D.W., and ULRICH, R. (2002). Generation of recombinant virus-like particles of human and non-human polyomavirus in yeast Saccharomyces cerevisiae. Intervirology 45, 308-317.
35. SHEN, A.L., HU, C.P., HSIA, R.C., TSAI, L.M., LEE, L.S., and CHANG, C.M. (1985). Cellular and antigenic properties of cultured normal and fetal brain and glioma cells. J. Neuroimmunol. 8, 141-151.
36. SLILATY, S.N., and APOSHIAN, H.V. (1983). Gene transfer by polyoma-like particles assembled in a cell-free system. Science 220, 725-727.
37. SLILATY, S.N., BERNS, K.I., and APOSHIAN, H.V. (1982). Polyoma-like particle: Characterization of the DNA encapsidated in vitro by polyoma empty capsids. J. Biol. Chem. 257, 6571-6575.
38. SOEDA, E., KRAUZEWICZ, N., COX, C., STOKROVA, J., FORSTOVA, J., and GRIFFIN, B.E. (1998). Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids. Gene Ther. 5, 1410-1419.
39. STOKROVA, J., PALKOVA, Z., FISHER, L., RICHTEROVA, Z., KORB, J., GRIFFIN, B.E., and FORSTOVA, J. (1999). Interactions of heterologous DNA with polyomavirus major structural protein, VP1. FEES Lett. 445, 119-125.
40. STRAYER, D.S., POMERANTZ, R.J., YU, M., ROSENZWEIG, M., BOUHAMDAN, M., YURASOV, S., JOHNSON, R.P., and GOLDSTEIN, H. (2000). Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors. Gene Ther. 7, 886-895.
41. SWEET, T.M., VALLE, L.D., and KHALILI, K. (2002). Molecular biology and immunoregulation of human neurotropic JC virus in CNS. J. Cell. Physiol. 191, 249-256.
42. TEGTMEYER, P., RUNDELL, K., and COLLINS, J.K. (1977). Modification of simian virus 40 protein A. J. Virol. 21, 647-657.
43. TOUZE, A., BOUSARGHIN, L., STER, C., COMBITA, A.L., ROINGEARD, P., and COURSAGET, P. (2001). Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells. J. Gen. Virol. 82, 3005-3009.
44. VACANTE, D.A., TRAUB, R., and MAJOR, E.O. (1989). Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. Virology 170, 353-361.
45. VALLE, L.D., GORDON, J., ASSIMAKOPOULOU, M., ENAM, S., GEDDES, J.F., VARAKIS, J.N., KATSETOS, C.D., CROUL, S., and KHALILI, K. (2001). Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res. 61, 4287-4293.
46. WAHEED, I., GUO, Z.S., CHEN, O.A., WEISER, T.S., NGUYEN, D.M., and SCHRUMP, D.S. (1999). Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells. Cancer Res. 59, 6068-6073.
47. WEI, G., LIU, C.K., and ATWOOD, W.J. (2000). JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T-lymphocytes. J. Neurovirol. 6, 127-136.
48. WHITE, F.A., ILL, M., STONER, G.L., and FRISQUE, R.J. (1992). JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J. Virol. 66, 5726-5734.